Earliest gestational age for fetal sexing in cell-free maternal plasma

被引:86
作者
Rijnders, RJP
Van der Luijt, RB
Peters, EDJ
Goeree, JK
Van Der Schoot, CE
Van Amstel, JKP
Christiaens, GCML
机构
[1] UMC Utrecht, Div Perinatol & Gynecol, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Div Med Genet, Utrecht, Netherlands
[3] Cent Lab Blood Transfus Red Cross, Amsterdam, Netherlands
关键词
fetal DNA; maternal plasma; earliest gestational age; SRY gene; RHD STATUS; RHESUS-D; DNA; DIAGNOSIS; SERUM; TIME; RISK;
D O I
10.1002/pd.750
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objectives To evaluate at what gestational age fetal DNA can reliably be detected at the earliest in maternal plasma. Methods We performed consecutive blood sampling in the first trimester of pregnancy in 17 women who were pregnant after in vitro fertilization (IVF) or intrauterine insemination (IUI). DNA was isolated and the Y-chromosome specific SRY was amplified by real-time polymerase chain reaction (PCR). We likewise studied 31 women prior to invasive prenatal diagnosis procedures for test validation purposes. All test results were compared to cytogenetic sex or sex at birth. Results The earliest SRY detection was at a gestational age of 5 weeks and 2 days. In none of 4 pregnancies ending in a miscarriage was SRY detected. We detected SRY in maternal plasma in I of 2 patients (50%) carrying a male fetus at a gestational age of 5 weeks, in 4 of 5 (80%) at a gestational age of 7 weeks, in 4 of 4 (100%) at a gestational age of 9 weeks. In all 7 women pregnant with a male fetus, the correct fetal sex was detected by 10 weeks. In none of the 6 patients who delivered a girl was SRY detected. In the validation group, SRY was detected in 13 of the 13 male, and none of the 18 female fetuses. Conclusions We conclude that real-time PCR of the SRY gene promises to be a reliable technique for early fetal sexing in maternal plasma. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:1042 / 1044
页数:3
相关论文
共 21 条
[1]   Fetal DNA in maternal serum: does it persist after pregnancy? [J].
Benachi, A ;
Steffann, J ;
Gautier, E ;
Ernault, P ;
Olivi, M ;
Dumez, Y ;
Costa, JM .
HUMAN GENETICS, 2003, 113 (01) :76-79
[2]   Fetal DNA in maternal plasma: The plot thickens and the placental barrier thins [J].
Bianchi, DW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (04) :763-764
[3]   Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR [J].
Bischoff, FZ ;
Ngyuen, DD ;
Marquéz-Do, D ;
Moise, KJ ;
Simpson, JP ;
Elias, S .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1999, 6 (02) :64-69
[4]   Fetal expressed gene analysis in maternal blood: A new tool for noninvasive study of the fetus [J].
Costa, JM ;
Benachi, A ;
Olivi, M ;
Dumez, Y ;
Vidaud, M ;
Gauthier, E .
CLINICAL CHEMISTRY, 2003, 49 (06) :981-983
[5]   First-trimester fetal sex determination in maternal serum using real-time PCR [J].
Costa, JM ;
Benachi, A ;
Gautier, E ;
Jouannic, JM ;
Ernault, P ;
Dumez, Y .
PRENATAL DIAGNOSIS, 2001, 21 (12) :1070-1074
[6]  
Gardner M.J., 1989, STAT CONFIDENCE
[7]   Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR [J].
González-González, MC ;
Trujillo, MJ ;
de Alba, MR ;
García-Hoyos, M ;
Lorda-Sánchez, I ;
Díaz-Recasens, J ;
Ayuso, C ;
Ramos, C .
PRENATAL DIAGNOSIS, 2003, 23 (03) :232-234
[8]   Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma [J].
González-González, MC ;
García-Hoyos, M ;
Trujillo, MJ ;
de Alba, MR ;
Lorda-Sánchez, I ;
Díaz-Recasens, J ;
Gallardo, E ;
Ayuso, C ;
Ramos, C .
PRENATAL DIAGNOSIS, 2002, 22 (10) :946-948
[9]  
Honda H, 2001, CLIN CHEM, V47, P41
[10]   Presence of fetal DNA in maternal plasma decades after pregnancy [J].
Invernizzi, P ;
Biondi, ML ;
Battezzati, PM ;
Perego, F ;
Selmi, C ;
Cecchini, F ;
Podda, M ;
Simoni, G .
HUMAN GENETICS, 2002, 110 (06) :587-591